Tag: Cochlear Limited



Cochlear Announces FDA Approval for Cochlear Implantation at 9 Months

The research and support in practice by trained hearing health professionals provided the foundation to approve the indication be lowered to 9 months, along with the considerable developments in technology and evolving speech coding strategies in modern day cochlear implant devices.

Cochlear Limited Supports WHO Hearing Health Policy Action Plan

Cochlear Limited (ASX: COH), Sydney, Australia, a global leader in implantable hearing solutions, welcomed the news that the World Health Assembly (WHA) has today supported a resolution that provides a hearing health policy action plan and recognizes the benefits of prevention, intervention, and treatment of hearing loss globally, Cochlear announced.

Read More